Omni Bio Pharmaceutical, Inc. (OTCBB: AAFS) recently announced that its common stock trading symbol on the OTCBB will change from AAFS to OMBP concurrence with its previously announced name change to Omni Bio Pharmaceutical, Inc. They symbol change will be effective with the commencement of trading on July 21, 2009.
Omni has been advancing broad-spectrum therapeutics targeting bacterial and viral diseases, biohazards, diabetes, and transplant rejection since February 2006. The Company's core technology is based on novel discoveries made at the University of Colorado involving therapeutic agents already approved for use in humans.
No comments:
Post a Comment